Laboratorios Farmaceuticos Rovi
ROVI.MC
#3546
Rank
NZ$5.07 B
Marketcap
$99.24
Share price
0.10%
Change (1 day)
-28.49%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2024 (TTM): NZ$0.37 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are NZ$0.87 Billion. In 2023 the company made an earning of NZ$0.42 Billion a decrease over its 2022 earnings that were of NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.37 B-10.56%
2023 NZ$0.42 B-12.68%
2022 NZ$0.48 B29.26%
2021 NZ$0.37 B149.39%
2020 NZ$0.14 B79.65%
2019 NZ$83.05 M128.8%
2018 NZ$36.29 M0.15%
2017 NZ$36.24 M-35.28%
2016 NZ$56 M27.59%
2015 NZ$43.89 M-32.06%
2014 NZ$64.61 M8.39%
2013 NZ$59.61 M-4.32%
2012 NZ$62.3 M2.78%
2011 NZ$60.61 M-2.15%
2010 NZ$61.95 M